Fibroblast growth factor 21 (FGF21) attenuates tacrolimus-induced hepatic lipid accumulation through transcription factor EB (TFEB)-regulated lipophagy

Zhensheng ZHANG; Li XU; Xun QIU; Xinyu YANG; Zhengxing LIAN; Xuyong WEI; Di LU; Xiao XU.
Journal of Zhejiang University. Science. B ; (12): 485-495, 2023.
Artículo en Inglés | WPRIM | ID: wpr-982389

Documentos relacionados

  1. Fibroblast growth factor 21 (FGF21) attenuates tacrolimus-induced hepatic lipid accumulation through transcription factor EB (TFEB)-regulated lipophagy.
  2. The tacrolimus-induced glucose homeostasis imbalance in terms of the liver: From bench to bedside.
  3. Glycyrrhizic acid improves tacrolimus-induced renal injury by regulating autophagy.
  4. Human kidney organoids model the tacrolimus nephrotoxicity and elucidate the role of autophagy.
  5. Pathway-level multi-omics analysis of the molecular mechanisms underlying the toxicity of long-term tacrolimus exposure.
  6. Effects of Wuzhi Capsule on Whole-Blood Tacrolimus Concentration Levels: A Systematic Review and Meta-Analysis.
  7. Analytical and Clinical Validation of Assays for Volumetric Absorptive Microsampling (VAMS) of Drugs in Different Blood Matrices: A Literature Review.
  8. Rapid intestinal and systemic metabolic reprogramming in an immunosuppressed environment.
  9. Effect of Klotho on autophagy clearance in tacrolimus-induced renal injury.
  10. Effects of tacrolimus on autophagy protein LC3 in puromycin-damaged mouse podocytes.